EXPOExponent, Inc.

Industrials

$69.79+2.0% 1Y

$69.79

$53.3952 weeks$79.04

Price

+2.0%1Y

End-of-day closes, not the intraday tick.

More going right than wrong

Quality mixed, no red flags, price roughly fair, growing in the filings, the market undecided.

RyuScore 72 of 100: see how it is built

What they do

We operate on a 52-53 week fiscal year with each year ending on the Friday closest to December 31st. Fiscal period 2025 included 52 weeks of activity and ended on January 2, 2026. Fiscal period 2024 included 53 weeks of activity and ended on January 3, 2025. Fiscal period 2023 included 52 weeks of activity and ended on December 29, 2023. Fiscal period 2026 is 52 weeks and will end on January 1, 2027. During 2025 billable hours decreased 2% to 1,468,000 as compared to 1,495,000 during 2024.

In the company’s own words · 10-K filed Feb 27, 2026 · SEC EDGAR

P/E31.3

Market value$2.81B

1 year+2.0%

5 years-35%

Charts

As reported to the SEC, without any scoring.

Exponent, Inc. (EXPO) reported revenue of $172M in Q2 2026 (quarter ended Jul 3, 2026), up 21% from the same quarter a year earlier. That came with net income of $29M (17% of revenue). For the full year FY2025, revenue was $582M (+4.2% year on year) and net income $106M. Its largest segment in Q2 2026 was Engineering And Other Scientific at $149M, 87% of the disclosed total, well ahead of Environmental And Health at 13%. The next results filing is expected around Oct 29, 2026, the same week as a year ago.

What the company said

The company's own words from its current reports to the SEC, newest first

Jul 30, 2026Exponent Reports Second Quarter 2026 Financial Results.Earnings release · press release
Apr 30, 2026Exponent Reports First Quarter 2026 Financial Results.Earnings release · press release
Apr 6, 2026Appointment of John D. Pye, Ph.D. On April 6, 2026, Exponent, Inc.’s (the “Company”) board of directors (the “Board”) appointed Dr. Pye as its President, effective as of May 1, 2026.Director or officer change · Form 8-K